background_placeholder
non-hodgkin

Articles about non-hodgkin

     
Kies meer

Trending
Er zijn @count nieuwe artikelen
Friday, August 12, 2022 - 12:16 - In Trending
The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: An economic evaluation of the ZUMA-7 trial
Friday, August 12, 2022 - 12:16 - In Trending
Pneumococcal conjugate vaccine does not induce humoral response when administrated within the six months after CD19 CAR T cell therapy
Tuesday, August 9, 2022 - 17:16 - In Trending
Diffuse large B?cell lymphoma of the Waldeyer’s ring: A U.S. Population?based survival analysis
Friday, July 15, 2022 - 12:16 - In Trending
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-cell Lymphomas
Friday, July 15, 2022 - 01:08 - In Trending
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma
Thursday, July 7, 2022 - 14:32 - In Trending
Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma
Friday, May 13, 2022 - 04:40 - In Trending
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
Monday, May 9, 2022 - 21:32 - In Wetenschap
April 2022: Drug Pipeline Updates?

Kies uw tags

gastric cancer
glioblastoom
myelofibrosis
urothelial cell carcinoma
mCRC
non-small cell lung carcinoma
colorectal liver metastases
skin cancer
eierstokkanker
cholangiocarcinoma